Caris Life Sciences, Inc.
USD15.48
-1.04 (-6.30%)
CEO
David Dean Halbert
IPO Date
2025-06-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.11
Prev. Close
$16.52
Day Low
$15.44
Day High
$16.11
52W Low
$14.19
52W High
$42.50
Market Cap
$4.38B
Volume
2.80M
| 9,771 |
| $15.25 |
| 18 May 2026 | Spetzler David Baxley | President | F-InKind | Disposed | 13,856 | $15.25 |
| 18 May 2026 | Brille Brian J | director, officer: See Remarks | F-InKind | Disposed | 13,987 | $15.25 |
| 18 May 2026 | HALBERT DAVID D | director, 10 percent owner, officer: See Remarks | F-InKind | Disposed | 40,712 | $15.25 |
| 12 May 2026 | Vacirca Jeff L | director | P-Purchase | Acquired | 31,050 | $16.15 |
| 10 Mar 2026 | Power Luke Thomas | See Remarks | A-Award | Acquired | 63,971 | $0.00 |
| 10 Mar 2026 | Denton John Russel | See Remarks | A-Award | Acquired | 63,971 | $0.00 |
| 10 Mar 2026 | Spetzler David Baxley | President | A-Award | Acquired | 83,162 | $0.00 |
| 10 Mar 2026 | Brille Brian J | director, officer: See Remarks | A-Award | Acquired | 83,162 | $0.00 |